← Back to search results

planningFind a Tender · planning
BuyerSecretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Statusplanning
DeadlineNot published
Value£1
Published12 Jun 2026

What is being bought

1. The purpose of this document is to enhance the Authority’s understanding of the marketplace and its options for sourcing for a potential future requirement. 2. The issuance of this request for information (RFI) does not constitute a sourcing exercise nor will the Authority pay any costs incurred in the preparation of a response to this RFI. 3. The UK Health Security Agency’s (UKHSA) key objectives for this RFI are: a. understand the ability of the marketplace to fulfil its requirements; b. refine the scope of the requirements to best align to the marketplace; and c. inform the Authority’s chosen route to market to best enable competition 4. The key dates for this RFI are as follows: 1. RFI Published: 12th June 2026 2. RFI Response: 10th July 2026 Description of Scope of Requirements: The UK Health Security Agency (UKHSA) is responsible for protecting every member of every community from the impact of infectious diseases, chemical, biological, radiological and nuclear incidents and other health threats. We provide intellectual, scientific and operational leadership at national and local level, as well as on the global stage, to make the nation's health secure. UKHSA sees access to oligonucleotide manufacturers as key to increasing the UK’s biosecurity, preparedness and resilience for infectious diseases. Oligonucleotides are a ubiquitous reagent used widely at many stages for research, development and use of diagnostics and countermeasures for infectious disease. Synthetic oligonucleotides are used widely as essential components of molecular diagnostic assays, sequencing methods and for development of serological assays, as well as critical reagents in the research, development and manufacture of new vaccines and therapeutics. The market for oligonucleotide supply in the UK, when you include use outside of infectious disease-related applications, is significant. UKHSA would like to understand the breadth and depth of oligonucleotide manufacturing capability in the UK and globally. This includes what oligonucleotides are already being manufactured, and to what design, what dependencies or bottlenecks exist, how these are being applied to make a product, and the existing and potential scale of manufacturing capacity. Although UKHSA is interested in understanding international manufacturing capability, UKHSA is specifically interested in improving onshore manufacturing capability for oligonucleotides and would encourage respondents to reflect any future intentions in the UK. This information will be used to inform UKHSA’s future approach to improve access to oligonucleotide products, and engagement with oligonucleotide manufacturers about UKHSA’s requirements. Should you wish to respond to this Request for Information, please complete the response questionnaire which is found at the following link: https://atamis-1928.my.salesforce-sites.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a07Pz00001dZ2lOIAS&searchStr=request+for+information&sortStr=Recently+Published&page=1&filters=&County=

Delivery location

UK, GB

Categories

Laboratory reagents 33696500

Lot details

Lot 1

No lot description published.

Statusplanning
Contract periodFrom 1 Apr 2027 to 1 Apr 2030
SME suitabilitySuitable for SMEs

What is included

ItemCategoryQuantity
1Laboratory reagentsNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 33. The category anchor is Laboratory reagents (33696500); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 334,8542 median · 122.5 average (2,278 of 4,854 with a bid count)5.8 average (2,724 of 4,854 with named award suppliers)Not published
Same buyer36Not publishedNot publishedNot published
Delivery region: UK1,4337 median · 323.1 average (652 of 1,433 with a bid count)10 average (788 of 1,433 with named award suppliers)Not published
Similar published value (0.5×–2×)59Not publishedNot publishedNot published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byNot published
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetValue not published
No-engagement rationaleNot published
Planning documents1
Planning milestones1
MilestoneTypeDueStatus
Request for Informationengagement10 Jul 2026scheduled

Related procurements

No linked framework, prior procurement or reprocurement published.

Documents & submission route

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-06b480
Latest release ID055938-2026
Latest release timestampFri Jun 12 2026 18:12:50 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statusplanning
Procurement methodNot published
Procurement method detailsNot published
Main procurement categorygoods
Above thresholdYes
Legal basis2023/54
Tender period: startNot published
Tender period: endNot published
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailsNot published
Submission languagesNot published
Electronic catalogue policyNot published
Total tender value£1
Tender lots in source1
Tender items in source1
Tender documents in source0
Awards in latest release0
Contracts in latest release0
Parties in latest release1

Notice history

DateEventReference
12 Jun 2026planning055938-2026

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "055938-2026",
  "tag": [
    "planning"
  ],
  "date": "2026-06-12T19:12:50+01:00",
  "ocid": "ocds-h6vhtk-06b480",
  "buyer": {
    "id": "GB-PPON-PBMQ-7576-DVGW",
    "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency"
  },
  "tender": {
    "id": "C450524",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "suitability": {
          "sme": true,
          "vcse": true
        },
        "contractPeriod": {
          "endDate": "2030-04-01T23:59:59+01:00",
          "startDate": "2027-04-01T00:00:00+01:00"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK",
            "country": "GB",
            "countryName": "United Kingdom"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33696500",
            "scheme": "CPV",
            "description": "Laboratory reagents"
          }
        ]
      }
    ],
    "title": "Request for Information – Oligonucleotides Onshoring",
    "value": {
      "amount": 1,
      "currency": "GBP",
      "amountGross": 1
    },
    "status": "planning",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "1. The purpose of this document is to enhance the Authority’s understanding of the marketplace and its options for sourcing for a potential future requirement.\n2. The issuance of this request for information (RFI) does not constitute a sourcing exercise nor will the Authority pay any costs incurred in the preparation of a response to this RFI.\n3. The UK Health Security Agency’s (UKHSA) key objectives for this RFI are:\na. understand the ability of the marketplace to fulfil its requirements;\nb. refine the scope of the requirements to best align to the marketplace; and\nc. inform the Authority’s chosen route to market to best enable competition\n4. The key dates for this RFI are as follows:\n1. RFI Published: 12th June 2026\n2. RFI Response: 10th July 2026\nDescription of Scope of Requirements:\nThe UK Health Security Agency (UKHSA) is responsible for protecting every member of every community from the impact of infectious diseases, chemical, biological, radiological and nuclear incidents and other health threats. We provide intellectual, scientific and operational leadership at national and local level, as well as on the global stage, to make the nation's health secure.\nUKHSA sees access to oligonucleotide manufacturers as key to increasing the UK’s biosecurity, preparedness and resilience for infectious diseases. Oligonucleotides are a ubiquitous reagent used widely at many stages for research, development and use of diagnostics and countermeasures for infectious disease. Synthetic oligonucleotides are used widely as essential components of molecular diagnostic assays, sequencing methods and for development of serological assays, as well as critical reagents in the research, development and manufacture of new vaccines and therapeutics.\nThe market for oligonucleotide supply in the UK, when you include use outside of infectious disease-related applications, is significant. UKHSA would like to understand the breadth and depth of oligonucleotide manufacturing capability in the UK and globally. This includes what oligonucleotides are already being manufactured, and to what design, what dependencies or bottlenecks exist, how these are being applied to make a product, and the existing and potential scale of manufacturing capacity. Although UKHSA is interested in understanding international manufacturing capability, UKHSA is specifically interested in improving onshore manufacturing capability for oligonucleotides and would encourage respondents to reflect any future intentions in the UK.\nThis information will be used to inform UKHSA’s future approach to improve access to oligonucleotide products, and engagement with oligonucleotide manufacturers about UKHSA’s requirements.\nShould you wish to respond to this Request for Information, please complete the response questionnaire which is found at the following link: https://atamis-1928.my.salesforce-sites.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a07Pz00001dZ2lOIAS&searchStr=request+for+information&sortStr=Recently+Published&page=1&filters=&County=",
    "communication": {
      "futureNoticeDate": "2026-12-01T23:59:59Z"
    },
    "aboveThreshold": true,
    "mainProcurementCategory": "goods"
  },
  "parties": [
    {
      "id": "GB-PPON-PBMQ-7576-DVGW",
      "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI42",
        "country": "GB",
        "locality": "London",
        "postalCode": "E14 4PU",
        "countryName": "United Kingdom",
        "streetAddress": "10 South Colonnade"
      },
      "details": {
        "url": "https://www.gov.uk/government/organisations/uk-health-security-agency",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PBMQ-7576-DVGW",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "name": "Josh Williams",
        "email": "joshua.williams@ukhsa.gov.uk"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "055938-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/055938-2026",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2026-06-12T19:12:50+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-07-10T23:59:59+01:00",
        "description": "Request for Information"
      }
    ]
  },
  "initiationType": "tender"
}
Complete JSON history (1 releases)
12 Jun 2026 · 055938-2026 · planning
{
  "id": "055938-2026",
  "tag": [
    "planning"
  ],
  "date": "2026-06-12T19:12:50+01:00",
  "ocid": "ocds-h6vhtk-06b480",
  "buyer": {
    "id": "GB-PPON-PBMQ-7576-DVGW",
    "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency"
  },
  "tender": {
    "id": "C450524",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "suitability": {
          "sme": true,
          "vcse": true
        },
        "contractPeriod": {
          "endDate": "2030-04-01T23:59:59+01:00",
          "startDate": "2027-04-01T00:00:00+01:00"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK",
            "country": "GB",
            "countryName": "United Kingdom"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33696500",
            "scheme": "CPV",
            "description": "Laboratory reagents"
          }
        ]
      }
    ],
    "title": "Request for Information – Oligonucleotides Onshoring",
    "value": {
      "amount": 1,
      "currency": "GBP",
      "amountGross": 1
    },
    "status": "planning",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "1. The purpose of this document is to enhance the Authority’s understanding of the marketplace and its options for sourcing for a potential future requirement.\n2. The issuance of this request for information (RFI) does not constitute a sourcing exercise nor will the Authority pay any costs incurred in the preparation of a response to this RFI.\n3. The UK Health Security Agency’s (UKHSA) key objectives for this RFI are:\na. understand the ability of the marketplace to fulfil its requirements;\nb. refine the scope of the requirements to best align to the marketplace; and\nc. inform the Authority’s chosen route to market to best enable competition\n4. The key dates for this RFI are as follows:\n1. RFI Published: 12th June 2026\n2. RFI Response: 10th July 2026\nDescription of Scope of Requirements:\nThe UK Health Security Agency (UKHSA) is responsible for protecting every member of every community from the impact of infectious diseases, chemical, biological, radiological and nuclear incidents and other health threats. We provide intellectual, scientific and operational leadership at national and local level, as well as on the global stage, to make the nation's health secure.\nUKHSA sees access to oligonucleotide manufacturers as key to increasing the UK’s biosecurity, preparedness and resilience for infectious diseases. Oligonucleotides are a ubiquitous reagent used widely at many stages for research, development and use of diagnostics and countermeasures for infectious disease. Synthetic oligonucleotides are used widely as essential components of molecular diagnostic assays, sequencing methods and for development of serological assays, as well as critical reagents in the research, development and manufacture of new vaccines and therapeutics.\nThe market for oligonucleotide supply in the UK, when you include use outside of infectious disease-related applications, is significant. UKHSA would like to understand the breadth and depth of oligonucleotide manufacturing capability in the UK and globally. This includes what oligonucleotides are already being manufactured, and to what design, what dependencies or bottlenecks exist, how these are being applied to make a product, and the existing and potential scale of manufacturing capacity. Although UKHSA is interested in understanding international manufacturing capability, UKHSA is specifically interested in improving onshore manufacturing capability for oligonucleotides and would encourage respondents to reflect any future intentions in the UK.\nThis information will be used to inform UKHSA’s future approach to improve access to oligonucleotide products, and engagement with oligonucleotide manufacturers about UKHSA’s requirements.\nShould you wish to respond to this Request for Information, please complete the response questionnaire which is found at the following link: https://atamis-1928.my.salesforce-sites.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a07Pz00001dZ2lOIAS&searchStr=request+for+information&sortStr=Recently+Published&page=1&filters=&County=",
    "communication": {
      "futureNoticeDate": "2026-12-01T23:59:59Z"
    },
    "aboveThreshold": true,
    "mainProcurementCategory": "goods"
  },
  "parties": [
    {
      "id": "GB-PPON-PBMQ-7576-DVGW",
      "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI42",
        "country": "GB",
        "locality": "London",
        "postalCode": "E14 4PU",
        "countryName": "United Kingdom",
        "streetAddress": "10 South Colonnade"
      },
      "details": {
        "url": "https://www.gov.uk/government/organisations/uk-health-security-agency",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PBMQ-7576-DVGW",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "name": "Josh Williams",
        "email": "joshua.williams@ukhsa.gov.uk"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "055938-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/055938-2026",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2026-06-12T19:12:50+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-07-10T23:59:59+01:00",
        "description": "Request for Information"
      }
    ]
  },
  "initiationType": "tender"
}